Tim Casey

News Connection
Clinical Pathways As Care Model
06/26/2013
Bruce Feinberg, DO, initially participated in a program focused on standardizing care for cancer patients in 1994. As the founder of Georgia Cancer Specialists, a group of oncologists based in Atlanta, he implemented a system in which...
Bruce Feinberg, DO, initially participated in a program focused on standardizing care for cancer patients in 1994. As the founder of Georgia Cancer Specialists, a group of oncologists based in Atlanta, he implemented a system in which...
Bruce Feinberg, DO, initially...
06/26/2013
First Report Managed Care
Treating Patients with Chronic Constipation or IBS
07/22/2014
Irritable bowel syndrome (IBS), is a disorder associated with abdominal pain and discomfort and an altered bowel habit.
Irritable bowel syndrome (IBS), is a disorder associated with abdominal pain and discomfort and an altered bowel habit.
Irritable bowel syndrome (IBS),...
07/22/2014
First Report Managed Care
Omacetaxine for CML
02/19/2014
New Orleans—After at least 24 months of follow-up, heavily pretreated patients with chronic phase or accelerated phase chronic myeloid leukemia (CML) had clinically meaningful and durable responses to omacetaxine, according to a subset...
New Orleans—After at least 24 months of follow-up, heavily pretreated patients with chronic phase or accelerated phase chronic myeloid leukemia (CML) had clinically meaningful and durable responses to omacetaxine, according to a subset...
New Orleans—After at least 24...
02/19/2014
First Report Managed Care
Abuse and Misuse of Opioid Medications
09/19/2013
Opioid medications have been proven effective in treating chronic pain; however, they are also associated with misuse, abuse, and diversion. 
Opioid medications have been proven effective in treating chronic pain; however, they are also associated with misuse, abuse, and diversion. 
Opioid medications have been...
09/19/2013
First Report Managed Care
News
Multiple Sclerosis Treatment Options
05/17/2013
As the FDA approves more drugs to treat multiple sclerosis, healthcare professionals are attempting to understand the costs, benefits, and risks associated with the various treatment options.
As the FDA approves more drugs to treat multiple sclerosis, healthcare professionals are attempting to understand the costs, benefits, and risks associated with the various treatment options.
As the FDA approves more drugs...
05/17/2013
First Report Managed Care
Lenalidomide for Mantle Cell Lymphoma
01/22/2013
Atlanta—Patients with mantle cell lymphoma who took lenalidomide had a 35% overall response rate to the drug and median progression-free survival of 8.8 months, according to a subset analysis of a phase 2, single-arm, open-label,...
Atlanta—Patients with mantle cell lymphoma who took lenalidomide had a 35% overall response rate to the drug and median progression-free survival of 8.8 months, according to a subset analysis of a phase 2, single-arm, open-label,...
Atlanta—Patients with mantle...
01/22/2013
First Report Managed Care
Choosing Wisely® Campaign Examines Unnecessary Tests and Procedures
10/22/2012
In a fee-for-service payment system, physicians are compensated for each test and procedure, creating an environment in which they are incentivized for the volume of care they provide. This situation has led to frustration for both patients...
In a fee-for-service payment system, physicians are compensated for each test and procedure, creating an environment in which they are incentivized for the volume of care they provide. This situation has led to frustration for both patients...
In a fee-for-service payment...
10/22/2012
First Report Managed Care
Medical Homes as Centerpiece of Healthcare Reform
06/19/2012
Orlando—In nearly 5 decades as a doctor, Sam JW Romeo has seen numerous industry innovations that did not improve care or cut costs. He is now the medical director at Tower Health & Wellness Center in Turlock, California, which he and other...
Orlando—In nearly 5 decades as a doctor, Sam JW Romeo has seen numerous industry innovations that did not improve care or cut costs. He is now the medical director at Tower Health & Wellness Center in Turlock, California, which he and other...
Orlando—In nearly 5 decades as a...
06/19/2012
First Report Managed Care
News
First-Year Cost of Administering and Monitoring Therapies for Multiple Sclerosis
01/25/2012
Madrid—According to an interactive tool developed to estimate the first-year cost of administering and monitoring multiple sclerosis (MS) therapies, glatiramer acetate was the cheapest treatment option, followed by interferon beta-1a...
Madrid—According to an interactive tool developed to estimate the first-year cost of administering and monitoring multiple sclerosis (MS) therapies, glatiramer acetate was the cheapest treatment option, followed by interferon beta-1a...
Madrid—According to an...
01/25/2012
First Report Managed Care
Counterfeit Medications Gaining Attention
10/14/2011
Although the accurate number and dollar value of counterfeit drugs are difficult to quantify, the issue has received attention recently in the United States because pharmaceutical companies are becoming more internationally based and because...
Although the accurate number and dollar value of counterfeit drugs are difficult to quantify, the issue has received attention recently in the United States because pharmaceutical companies are becoming more internationally based and because...
Although the accurate number and...
10/14/2011
First Report Managed Care

Upcoming Events

Advances in Inflammatory Bowel Disease Regionals
April 5 ⁠–⁠ April 6
Rx summit logo
April 21 ⁠–⁠ April 24
April 29 ⁠–⁠ April 30
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 4
Psych Congress Regionals
May 1 ⁠–⁠ May 2
May 7 ⁠–⁠ May 9
NEI Congress
May 8 ⁠–⁠ May 10
Dermatology Week
May 14 ⁠–⁠ May 16
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
May 28 ⁠–⁠ May 31
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use